Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis

References

• Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol 2007;18(Suppl. 1):i3–i8.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, . Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300.
   PubMed Web of Science ®Google Scholar
• Descatha A, Jenabian A, Conso F, . Occupational exposures and haematological malignancies: overview on human recent data. Cancer Causes Control 2005;16:939–953.
   PubMed Web of Science ®Google Scholar
• Irigaray P, Newby JA, Clapp R, . Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 2007;61:640–658.
   PubMed Web of Science ®Google Scholar
• Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007;92:960–969.
   PubMed Web of Science ®Google Scholar
• Koppen IJ, Hermans FJ, Kaspers GJ. Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 2010;148:3–14.
   PubMed Web of Science ®Google Scholar
• Lehman NL. Future potential of thymidylate synthase inhibitors in cancer therapy. Expert Opin Investig Drugs 2002;11:1775–1787.
   PubMed Web of Science ®Google Scholar
• Horie N, Aiba H, Oguro K, . Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5’-terminal regulatory region of the human gene for thymidylate synthase. Cell struct funct 1995;20:191–197.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Omura K, Kanehira E, . Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 1999;19:3249–3252.
   PubMed Web of Science ®Google Scholar
• Ulrich CM, Bigler J, Velicer CM, . Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 2000;9:1381–1385.
   PubMed Web of Science ®Google Scholar
• Chu J, Dolnick BJ. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochim Biophys Acta 2002;1587:183–193.
   PubMed Web of Science ®Google Scholar
• Gao CM, Takezaki T, Wu JZ, . Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac J Cancer Prev 2004;5:133–138.
   PubMedGoogle Scholar
• de Jonge R, Tissing WJ, Hooijberg JH, . Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009;113:2284–2289.
   PubMed Web of Science ®Google Scholar
• Giovannetti E, Ugrasena DG, Supriyadi E, . Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leuk Res 2008;32:19–24.
   PubMed Web of Science ®Google Scholar
• Bolufer P, Collado M, Barragan E, . The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 2007;92:308–314.
   PubMed Web of Science ®Google Scholar
• Petra BG, Janez J, Vita D. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 2007;48:786–792.
   PubMed Web of Science ®Google Scholar
• Lightfoot TJ, Skibola CF, Willett EV, . Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 2005;14:2999–3003.
   PubMed Web of Science ®Google Scholar
• Hishida A, Matsuo K, Hamajima N, . Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003;88:159–166.
   PubMed Web of Science ®Google Scholar
• Skibola CF, Smith MT, Hubbard A, . Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002;99:3786–3791.
   PubMed Web of Science ®Google Scholar
• Ongaro A, De Mattei M, Della Porta MG, . Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. Haematologica 2009;94:1391–1398.
   PubMed Web of Science ®Google Scholar
• da Silva Silveira V, Canalle R, Scrideli CA, . Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 2009; 33:898–901.
   PubMed Web of Science ®Google Scholar
• Dulucq S, St-Onge G, Gagne V, . DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood 2008;111:3692–3700.
   PubMed Web of Science ®Google Scholar
• Rocha JC, Cheng C, Liu W, . Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005;105:4752–4758.
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Lemieux-Blanchard E, Chiasson S, . Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 2004;4:66–72.
   PubMed Web of Science ®Google Scholar
• Costea I, Moghrabi A, Krajinovic M. The influence of cyclin D1 (CCND1) 870A > G polymorphism and CCND1-thymidylate synthase (TS) gene-gene interaction on the outcome of childhood acute lymphoblastic leukaemia. Pharmacogenetics 2003;13:577–580.
   PubMedGoogle Scholar
• Lauten M, Asgedom G, Welte K, . Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia. Haematologica 2003;88:353–354.
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Costea I, Chiasson S. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet 2002;359:1033–1034.
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Costea I, Primeau M, . Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis. Pharmacogenomics J 2005;5:374–380.
   PubMed Web of Science ®Google Scholar
• de Jonge R, Hooijberg JH, van Zelst BD, . Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood 2005;106:717–720.
   PubMed Web of Science ®Google Scholar
• Liani E, Rothem L, Bunni MA, . Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Int J Cancer 2003;103:587–599.
   PubMed Web of Science ®Google Scholar
• Drori S, Jansen G, Mauritz R, . Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. J Biol Chem 2000;275:30855–30863.
   PubMed Web of Science ®Google Scholar
• Robien K, Bigler J, Yasui Y, . Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 2006;12:973–980.
   PubMed Web of Science ®Google Scholar
• Robien K, Schubert MM, Chay T, . Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation. Bone Marrow Transplant 2006;37:799–800.
   PubMed Web of Science ®Google Scholar
• Relling MV, Yang W, Das S, . Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004;22:3930–3936.
   PubMed Web of Science ®Google Scholar
• Chen XW, Yue LJ, Li CG, . [Polymorphisms of thymidylate synthase gene detected by RT-PCR-denaturing gradient gel electrophoresis in children with acute leukemia]. Zhongguo Dang Dai Er Ke Za Zhi 2009;11:251–254.
   PubMedGoogle Scholar
• Yeoh AE, Lu Y, Chan JY, . Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res 2010; 34:276–283.
   PubMed Web of Science ®Google Scholar
• Kurzwelly D, Knop S, Guenther M, . Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. J Neurooncol 2010;100:187–192.
   PubMed Web of Science ®Google Scholar
• Chan JY, Ugrasena DG, Lum DW, . Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 2011;29:116–123.
   PubMed Web of Science ®Google Scholar
• Kim HN, Kim YK, Lee IK, . Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk Res 2009;33:82–87.
   PubMed Web of Science ®Google Scholar
• Berglund M, Enblad G, Turesson I, . Folate-metabolizing genes in lymphoma patients from Sweden. Scand J Immunol 2009;70:408–410.
   PubMed Web of Science ®Google Scholar
• Lima CS, Ortega MM, Ozelo MC, . Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res 2008;32:401–405.
   PubMed Web of Science ®Google Scholar
• Kim HN, Lee IK, Kim YK, . Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008;140:287–294.
   PubMed Web of Science ®Google Scholar
• Kim HN, Kim YK, Lee IK, . Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. Am J Hematol 2007;82:798–801.
   PubMed Web of Science ®Google Scholar
• Niclot S, Pruvot Q, Besson C, . Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 2006;108:278–285.
   PubMed Web of Science ®Google Scholar
• Skibola CF, Forrest MS, Coppede F, . Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004;104:2155–2162.
   PubMed Web of Science ®Google Scholar
• Canalle R, Silveira VS, Scrideli CA, . Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2011;52:1118–1126.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Ahmadian Z, Akramipour R, . Thymidylate synthase and methionine synthase polymorphisms are not associated with susceptibility to childhood acute lymphoblastic leukemia in Kurdish population from Western Iran. Mol Biol Rep 2011 Jun 5. [Epub ahead of print]
   Google Scholar
• Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 2011;34:101–109.
   PubMed Web of Science ®Google Scholar
• McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene 2004;23:6349–6364.
   PubMed Web of Science ®Google Scholar
• Sauer J, Mason JB, Choi SW. Too much folate: a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 2009;12:30–36.
   PubMed Web of Science ®Google Scholar
• Mandola MV, Stoehlmacher J, Zhang W, . A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 2004;14:319–327.
   PubMedGoogle Scholar
• Lincz LF, Scorgie FE, Garg MB, . Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele. Int J Cancer 2007;120:1930–1934.
   PubMed Web of Science ®Google Scholar
• Rouissi K, Ouerhani S, Oliveira E, . Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet 2009;195:43–53.
   PubMed Web of Science ®Google Scholar